Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
David Malebranche's former patient tried to get PEP at a major Atlanta HIV clinic and was initally denied. Though the situation has been made right, it's important to make sure this doesn't happen again.
March 26, 2020: Lopinavir/ritonavir falls short against COVID-19; impact of PrEP scale-up on HIV diagnoses; long-term cost-effectiveness of various HIV interventions; disparities in virologic suppression among young people.
Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed
Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.
Our Newest Posts
April 2, 2020: Physical activity vs. heart med adherence; reducing the burden of HIV emergency care; increasing smoking cessation intervention success; virologic failure following asymptomatic HIV treatment initiation.
At least one such drug still holds that promise against coronavirus, but in general there’s little precedent for the same drug blocking different viruses.
Advocates and public health organizations say the 2015 policy revision still stigmatizes gay men and isn’t based on science.
Widely respected by U.S. and African activists for her work on global AIDS, she’s also increasingly seen as playing fast and loose with COVID facts to appease President Trump.
Addressing Coronavirus in African Countries With High HIV Rates: An Interview With UNAIDS Head Winnie Byanyima
Byanyima discusses COVID-19, HIV, and the power of the community response.
Thirty years ago, the NIH legend deftly negotiated between bureaucrats and activists. As part of Trump’s COVID-19 team, can he negotiate between loyalty and truth?